Journal ArticleOPEN ACCESS

Attack on amyloid-β protein

  • Reiman E
Nature (2016) 537(7618) 36-37
DOI: 10.1038/537036a
N/ACitations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An antibody therapy markedly reduces aggregates of amyloid-β, the hallmark protein of Alzheimer's disease, and might slow cognitive decline in patients. Confirmation of a cognitive benefit would be a game-changer. See Article p.50

Cite

CITATION STYLE

APA

Reiman, E. M. (2016). Attack on amyloid-β protein. Nature, 537(7618), 36–37. https://doi.org/10.1038/537036a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free